ArticleScientific reports2026
Protective effects of rutin and quercetin against diazinon-induced toxicity in Wistar Rat Liver.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diazinon is extensively used as an insecticide or pesticide in agriculture. This insecticide can be absorbed by the human body through inhalation, oral ingestion, and skin, leading to human poisoning. The liver is the first organ affected by diazinon. The present study focused on the recovery of antioxidant biomarkers, including malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and reduced glutathione (GSH), in addition to the acetylcholinesterase activity (AChE), using two flavonoids, namely rutin and quercetin, in the rat liver. The antioxidant properties of these two compounds are well-established. The results show that both rutin and quercetin at a dosage of 200 mg/kg can reduce the malondialdehyde and improve the other markers and acetylcholinesterase, with quercetin being more effective. Quercetin, owing to its superior antioxidant activity and higher bioavailability compared to rutin, effectively restored antioxidant enzyme activities (SOD, CAT, and GSH) and AChE levels in the liver of diazinon-poisoned rats to near control values. The current study suggests that quercetin is a more effective therapeutic agent than rutin for mitigating diazinon-induced hepatic oxidative stress and toxicity by scavenging ROS, inhibiting lipid peroxidation, and restoring redox homeostasis. Accordingly, quercetin can be considered as a potential treatment for diazinon poisoning. However, more animal, cellular, and clinical studies are necessary for prescribing and final approval for use in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.